Abstract

BackgroundMicroRNAs (miRNAs) have been reported to play crucial roles in multiple cancers including non-small cell lung cancer (NSCLC). Here, we investigated the role of miR-145 and miR-497 in TGF-β-induced epithelial–mesenchymal transition (EMT) process of NSCLC.MethodsWe performed quantitative real time PCR (qRT-PCR) to detect the expression level of miR-145 and miR-497 in NSCLC cell lines. Then in the presence/absence of TGF-β, we transfected miRNA mimics or inhibitor into A549 and H1299 cells and investigated the role of miR-145 and miR-497 in cell migration and invasion using transwell and wound-healing assay. The regulation role of miR-145 and miR-497 on Metadherin (MTDH) was determined by luciferase assay. The expression level of MTDH and EMT markers E-cadherin and vimentin were detected on mRNA and protein level.ResultsIn our study, our results showed that miR-145 and miR-497 were downregulated in NSCLC cell lines. Overexpression of miR-145 and miR-497 inhibited TGF-β-induced EMT and suppressed cancer cell migration and invasion, while the opposite results were observed in cells transfected with miR-145 or miR-497 inhibitor. Moreover, the luciferase assay confirmed that miR-145 and miR-497 attenuated MTDH expression by directly binding 3′-UTR of MTDH mRNA and exert the tumor-suppression role.ConclusionsOverall, we demonstrated that miR-145 and miR-497 functioned as EMT-suppressor in NSCLC by targeting MTDH, provided new evidence that miR-145 and miR-497 as potential therapeutic targets.

Highlights

  • MicroRNAs have been reported to play crucial roles in multiple cancers including non-small cell lung cancer (NSCLC)

  • Results miR‐145 and miR‐497 are downregulated in NSCLC cell lines The expression levels of miR-145 and miR-497 in three NSCLC cell lines (A549, H1299 and H358) and human bronchial epithelial cell line (HBE) cell line were detected

  • Compared with HBE, miR-145 and miR-497 decreased in all the NSCLC cell lines (Fig. 1a, b)

Read more

Summary

Introduction

MicroRNAs (miRNAs) have been reported to play crucial roles in multiple cancers including non-small cell lung cancer (NSCLC). The majority (79%) of non-small cell lung cancer (NSCLC) patients develop metastases from their primary tumor [1]. MTDH is upregulated in multiple cancer tissues and cell lines, induce EMT via oncogenic signaling pathways including PI3 K/Akt, ERK, Wnt/β-catenin signaling, enhance tumor metastasis [11,12,13,14]. Elevated MTDH expression correlated with increased NSCLC proliferation and metastasis and predicted worse prognosis in patients [15,16,17]. These results demonstrated that MTDH may act as an important metastasis promoter in cancer development

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.